Skip to main navigation Skip to search Skip to main content

Angiogenesis in cutaneous lesions of leprosy: Implications for treatment

  • Sulochana S. Bhandarkar
  • , Cynthia Cohen
  • , Maria Kuruvila
  • , Thomas H. Rea
  • , Jamie B. MacKelfresh
  • , Delphine J. Lee
  • , Robert L. Modlin
  • , Jack L. Arbiser*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To examine the potential role of angiogenesis in leprosy. Design: Immunohistochemical analysis of leprosy lesions. Setting: Department of Dermatology, Venereology, and Leprology, Kasturba Medical College; Division of Dermatology, University of California at Los Angeles; and Departments of Dermatology and Pathology, Emory University. Patients: Thirty-two cutaneous lesions that represented the spectrum of leprosy were obtained from 32 patients. Main Outcome Measure: CD31 microvessel counts. Results: The mean CD31 microvessel count in borderline tuberculoid, midborderline, and lepromatous leprosy lesions was significantly higher than in indeterminate leprosy lesions. Conclusions: Increased bacterial load is associated with increased angiogenesis. Angiogenesis inhibitors may be of benefit in the treatment of leprosy.

Original languageEnglish
Pages (from-to)1527-1529
Number of pages3
JournalArchives of Dermatology
Volume143
Issue number12
DOIs
Publication statusPublished - 01-12-2007

All Science Journal Classification (ASJC) codes

  • Dermatology

Fingerprint

Dive into the research topics of 'Angiogenesis in cutaneous lesions of leprosy: Implications for treatment'. Together they form a unique fingerprint.

Cite this